InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
4
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-65.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Neil Garry Arthur. Officer active across 4 companies, notably Cerecor Inc.. In total, 11 reports have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €34k. History available since 10 June 2021. The latest transaction was disclosed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Neil Garry Arthur
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
100,200 股0Common StockSEC:0001586785-26-000006:0
64,866 股Common StockSEC:0001586785-26-000004:0
21,892 股@ US$13.890.078% mcap60.4% 占其流量Common StockSEC:0001586785-26-000004:1
64,867 股Common StockSEC:0001578563-25-000197:0
17,787 股@ US$8.4631.9% 占其流量Common StockSEC:0001578563-25-000197:1
4,000 股@ US$3.422.9% 占其流量Common StockSEC:0001628280-23-021958:0
标准退出：2023年9月7日 (T+90)
2,083 股@ US$4.422.0% 占其流量Common StockSEC:0001628280-22-031725:0
标准退出：2023年3月9日 (T+90)
8,150 股Common StockSEC:0001628280-22-005912:0
4,267 股@ US$1.571.4% 占其流量Common StockSEC:0001879785-21-000037:0
标准退出：2022年3月10日 (T+90)
3,067 股0Common StockSEC:0001628280-21-012275:0
3,692 股@ US$2.28100.0% 占其流量Common StockSEC:0001192482-21-000501:0
标准退出：2021年9月8日 (T+90)
11 条申报中的 11 条
About Neil Garry Arthur
NEIL GARRY ARTHUR is a declarant linked to Avalo Therapeutics, Inc., Arena Pharmaceuticals INC and Cerecor Inc., with 11 filings in total. Across the 11 sampled recent filings, buy transactions total 34253 EUR, sell transactions are 0, and the period runs from 2021-06-14 to 2026-05-26.
